Objective: To determine the frequency of patients with atherosclerotic cardiovascular disease receiving High Intensity Statin Therapy and types & doses of Statin.
Methods: For this cross-sectional study we enrolled patients above 20 years of age with definitive diagnosis of coronary artery disease presenting at department of our Institute. Demographic characteristics and risk factors such as DM, hypertension, dyslipidemia, and smoking status and information regarding cardiac history, statin therapy, type and dosage level were obtained on a pre designed structural questionnaire.
Results: A total of 238 patients were enrolled in this study, out of which 73.9% (176) were male, mean age of the patients was 56.29 ± 11.94 years. At baseline 41.6% (99) were diabetic, 74.4% (177) were hypertensive, 46.2% (110) were dyslipidemic, 14.7% (35) were current smokers.
Asprin was prescribed to 91.2% (217) of the patients, Clopidogrel to 59.7% (142) patients, Beta Blockers to 78.2% (186) patients, ACE/ ARB to 67.6% (161) patients, and CCB were prescribed to 9.7% (23) patients. Statin was prescribed to 94.5% (225) patients, 29.8% (71) were prescribed with Atorvastatin (10 mg to 50.7%, 20 mg to 47.9%, 40 mg to 1.4%, and 80 mg to 0%) and 66.8% (159) were prescribed with Rosuvastatin (5 mg to 1.9%, 10 mg to 28.3%, 20 mg to 69.2%, and 40 mg to 0.6%). High Intensity Statin Therapy was received by 47.1% (112) patients.
Conclusion: Majority of the patients did not receive High Intensity Statin Therapy after hospitalization for atherosclerotic cardiovascular disease. Whereas, the recent American College of Cardiology(ACC/AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults recommends initiation of high-intensity statin therapy. Reinforcement of guideline in practice is necessary for the better management of our patients.